This book presents the main results of the first large-scale effort to exploit firm-level data from innovation surveys across 20 countries in an internationally harmonised way, with a view to addressing common analytical questions.
This book reviews how the emergence of pharmacogenetics will impact the efficiency of pharmaceutical R&D and improve healthcare decision making and clinical care. It discusses what policies need to change in order for the public to reap the benefits from advances in diagnostic genetic testin
Cette recommandation fournit des orientations en matière de constitution, de gouvernance, de gestion, de fonctionnement, d’accès, d’utilisation et de fermeture des BGH.
English, , 826kb
The Database on Research into the Safety of Manufactured Nanomaterials (the Database) develops a global resource, which identifies research projects that address human health and environmental safety issues associated with manufactured nanomaterials.
This workshop, sponsored by Japan, Germany, the Netherlands and Norway under the auspices of the OECD Committee for Scientific and Technological Policy (CSTP).
English, , 4,506kb
This report, Applications of Complexity: Science for Public Policy: New Tools for Finding Unanticipated Consequences and Unrealised Opportunities, is a product of the Global Science Forum.
This publication assesses the current status of Mexico's innovation system and policies, and identifies where and how the government should focus its efforts to improve the country’s innovation capabilities.
The findings and views emerging from the workshop will contribute to the development of the OECD Innovation Strategy to be presented to OECD Ministers in 2010.
This workshop brought together policy makers, economists, and business representatives to share their views and experience in fostering demand for innovation via market and public policy instruments including public procurement, pricing, regulations, standards-setting and lead markets.
This Guidance Manual for the Testing of Manufactured Nanomaterials, is a “living document” and as such, it will be updated and amended in an iterative manner based upon knowledge accumulation as the testing programme and Dossier Development Plans (DDPs) work progresses.